Log In
BCIQ
Print this Print this
 

GeneSight Analgesic

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionPharmacogenetic test that analyzes pharmacokinetic genes from the Cytochrome P450 family and pharmacodynamic genes that mediate the analgesic effects of opioid medications
Molecular Target Cytochrome P450 (p450)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationPersonal genomics testing
Indication DetailsPredict response to opioid medications
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$410.0M

$225.0M

$185.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/01/2016

$410.0M

$225.0M

$185.0M

Get a free BioCentury trial today